Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluation

There is significant geographic variation in metastatic prostate cancer incidence at diagnosis, with a higher incidence of metastatic cancer observed in areas with a lower overall prostate cancer incidence and in more socioeconomically deprived neighbourhoods, which likely contributes to poorer long-term outcomes. The findings highlight the need for a targeted, risk-based diagnostic approach as well as improved diagnostic facilities and referral pathways. Further research is needed to understand the factors driving this variation in order to reduce metastatic presentations and tackle inequalities in prostate cancer outcomes.

Authors

Institutions

Publication Details

Journal
BMJ Oncology
Published
2025-04-01
DOI
https://doi.org/10.1136/bmjonc-2024-000643
Citations
6
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
9.11
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluation

Thomas E. Cowling, Adrian David Cook, Jan van der Meulen, Marina Parry et al.
6 citations
BMJ Oncology
Prostate Cancer Treatment and Research
9.11
article

Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluation

Thomas E. Cowling, Adrian David Cook, Jan van der Meulen, Marina Parry, Ajay Aggarwal, Joanna Dodkins, Noel W. Clarke, Julie Nossiter, Emily Mayne, Heather Payne, Alison Tree
article en
6 citations

Abstract

There is significant geographic variation in metastatic prostate cancer incidence at diagnosis, with a higher incidence of metastatic cancer observed in areas with a lower overall prostate cancer incidence and in more socioeconomically deprived neighbourhoods, which likely contributes to poorer long-term outcomes. The findings highlight the need for a targeted, risk-based diagnostic approach as well as improved diagnostic facilities and referral pathways. Further research is needed to understand the factors driving this variation in order to reduce metastatic presentations and tackle inequalities in prostate cancer outcomes.

BMJ OncologyVol. 4(1)
Royal Marsden NHS Foundation Trust (GB), Institute of Cancer Research (GB), Royal College of Surgeons of England (GB), Guy's and St Thomas' NHS Foundation Trust (GB), London School of Hygiene & Tropical Medicine (GB), The Christie NHS Foundation Trust (GB), The Prostate Centre (GB)
No poverty
Openalex Percentile: Top 2%
Prostate Cancer Treatment and Research
9.11
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluation — Thomas E. Cowling, Adrian David Cook, et al. · BMJ Oncology (2025) | TGRS Research Map | TGRS